Larvol Delta - Sonelokimab-a-novel-IL17A-and-IL17Finhibiting-Nanobody-in-moderatetosevere-palmoplantar-pustulosis-Efficacy-safety-and-translational-results-from-the-openlabel-Phase-2-LEDA-trial

sonelokimab (M1095) - Avillion, MoonLake Immunotherap

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/62099

Nina Magnolo

Jun 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next